Treatment of platinum nonresponsive metastatic malignant peritoneal mesothelioma with combination chemoimmunotherapy Journal Article


Authors: Foote, M. B.; Shia, J.; Zauderer, M. G.; Nash, G. M.; Cercek, A.
Article Title: Treatment of platinum nonresponsive metastatic malignant peritoneal mesothelioma with combination chemoimmunotherapy
Abstract: Malignant peritoneal mesothelioma is a rare cancer associated with minimal durable disease control with chemotherapy and poor overall survival. The efficacy of combined cytotoxic chemotherapy and immune checkpoint inhibitors (ICIs) in malignant peritoneal mesothelioma has not previously been studied. We describe the clinical course of 2 patients with metastatic peritoneal mesothelioma who both relapsed with platinum nonresponsive disease after initial cytoreductive surgery and chemotherapy. In both cases, addition of pembrolizumab to platinum and pemetrexed treatment resulted in a substantial partial and a near complete disease response. Notably, both patients possessed tumors without validated biomarkers of ICI response, including low tumor mutational burden and negative programmed death ligand-1. The unique genomic landscape of each patient may have enabled increased tumor immunorecognition and ICI efficacy. In addition, chemotherapy priming of the tumor microenvironment may have improved ICI response. This report supports future research to characterize the benefit of combination chemotherapy and ICI in peritoneal mesothelioma. © 2022 Lippincott Williams and Wilkins. All rights reserved.
Keywords: immunotherapy; peritoneal mesothelioma; immune checkpoint inhibitor; pembrolizumab
Journal Title: Journal of Immunotherapy
Volume: 45
Issue: 2
ISSN: 1524-9557
Publisher: Lippincott Williams & Wilkins  
Date Published: 2022-02-01
Start Page: 100
End Page: 103
Language: English
DOI: 10.1097/cji.0000000000000399
PUBMED: 34723916
PROVIDER: scopus
PMCID: PMC8810621
DOI/URL:
Notes: Article -- Export Date: 1 March 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jinru Shia
    720 Shia
  2. Marjorie G Zauderer
    189 Zauderer
  3. Garrett Nash
    267 Nash
  4. Michael Bonner Foote
    46 Foote